GT200800253A - Sales y modificaciones del cristal de las mismas - Google Patents

Sales y modificaciones del cristal de las mismas

Info

Publication number
GT200800253A
GT200800253A GT200800253A GT200800253A GT200800253A GT 200800253 A GT200800253 A GT 200800253A GT 200800253 A GT200800253 A GT 200800253A GT 200800253 A GT200800253 A GT 200800253A GT 200800253 A GT200800253 A GT 200800253A
Authority
GT
Guatemala
Prior art keywords
salts
same
crystal
modifications
phenyl
Prior art date
Application number
GT200800253A
Other languages
English (en)
Inventor
Feng Lili
Jiang Xinglong
Karpinski Piortr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200800253A publication Critical patent/GT200800253A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCIÓN SE REFIERE A SALES DE 1-(2-FLUORO-FENIL)-3-(2-OXO-5-FENIL-2,3-DIHIDRO-1H-BENZO-[E]-[1,4]-DIAZEPIN-3-IL)-UREA, Y A LAS FORMAS CRISTALINAS DE LAS MISMAS, A SU PRODUCCIÓN Y USO, Y A PREPARACIONES FARMACÉUTICAS QUE CONTIENEN ESTAS SALES Y FORMAS CRISTALINAS. T2008
GT200800253A 2006-05-23 2008-11-21 Sales y modificaciones del cristal de las mismas GT200800253A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80283606P 2006-05-23 2006-05-23

Publications (1)

Publication Number Publication Date
GT200800253A true GT200800253A (es) 2009-04-29

Family

ID=38704747

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800253A GT200800253A (es) 2006-05-23 2008-11-21 Sales y modificaciones del cristal de las mismas

Country Status (28)

Country Link
US (1) US7977330B2 (es)
EP (1) EP2029556B1 (es)
JP (2) JP2009538330A (es)
KR (1) KR20090009898A (es)
CN (1) CN101448796B (es)
AR (1) AR061056A1 (es)
AT (1) ATE486858T1 (es)
AU (1) AU2007267671A1 (es)
BR (1) BRPI0712556A2 (es)
CA (1) CA2650514A1 (es)
CL (1) CL2007001454A1 (es)
CR (1) CR10431A (es)
DE (1) DE602007010286D1 (es)
EC (1) ECSP088900A (es)
ES (1) ES2355166T3 (es)
GT (1) GT200800253A (es)
IL (1) IL195008A0 (es)
MA (1) MA30482B1 (es)
MX (1) MX2008014836A (es)
NO (1) NO20085000L (es)
PE (1) PE20080261A1 (es)
PL (1) PL2029556T3 (es)
PT (1) PT2029556E (es)
RU (1) RU2008150627A (es)
TN (1) TNSN08477A1 (es)
TW (1) TW200815375A (es)
WO (1) WO2007140154A2 (es)
ZA (1) ZA200809096B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012387B1 (ru) * 2002-09-20 2009-10-30 Эрроу Терапьютикс Лимитед Производные бензодиазепина, содержащие их продукт и фармацевтическая композиция и их применение

Also Published As

Publication number Publication date
IL195008A0 (en) 2009-08-03
ATE486858T1 (de) 2010-11-15
CN101448796A (zh) 2009-06-03
US20090163478A1 (en) 2009-06-25
DE602007010286D1 (de) 2010-12-16
EP2029556A2 (en) 2009-03-04
AR061056A1 (es) 2008-07-30
TNSN08477A1 (en) 2010-04-14
MA30482B1 (fr) 2009-06-01
PE20080261A1 (es) 2008-04-18
CL2007001454A1 (es) 2008-05-16
EP2029556B1 (en) 2010-11-03
CN101448796B (zh) 2012-09-26
WO2007140154A3 (en) 2008-03-20
MX2008014836A (es) 2008-12-01
BRPI0712556A2 (pt) 2013-07-02
AU2007267671A1 (en) 2007-12-06
WO2007140154A2 (en) 2007-12-06
JP2009538330A (ja) 2009-11-05
KR20090009898A (ko) 2009-01-23
JP2013075910A (ja) 2013-04-25
ES2355166T3 (es) 2011-03-23
RU2008150627A (ru) 2010-06-27
CA2650514A1 (en) 2007-12-06
TW200815375A (en) 2008-04-01
NO20085000L (no) 2008-12-23
PL2029556T3 (pl) 2011-04-29
PT2029556E (pt) 2011-01-31
ZA200809096B (en) 2009-11-25
ECSP088900A (es) 2008-12-30
CR10431A (es) 2009-01-07
US7977330B2 (en) 2011-07-12

Similar Documents

Publication Publication Date Title
ECSP10010178A (es) Derivados bis-(sulfonilamino) en terapia 066
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
UY30327A1 (es) Nuevos compuestos ii
DOP2010000191A (es) Derivados bis-(sulfonilamino)
UY30328A1 (es) Derivados de 2-piridona, procesos de preparacion, composiciones conteniéndolos y aplicaciones.
DOP2010000134A (es) Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos
ECSP077271A (es) Derivados de pirimidina
UY29549A1 (es) Nuevos derivados del fluoreno, composiciones que los contienen y su utilización
ECSP078030A (es) Formas cristalinas y otras formas de las sales de ácido láctico de 4-amino-5-fluoro-3-[6-(4-metilpiperazin -1-il)-1h-bencimidazol-2 -il]-1h-quinolin-2-ona
ECSP077259A (es) Derivados de pirimidina
ECSP066365A (es) Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk
ECSP099476A (es) Compuestos carboxamida y su uso como inhibidores de calpaína
ECSP099378A (es) Compuestos y composiciones como inhibidores de la proteina quinasa
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
ECSP055738A (es) PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL
UY28348A1 (es) Compuestos novedosos
CR20110100A (es) Nuevos derivados de sulfamida sustituida
ECSP045221A (es) Sales de valsartan
PA8720801A1 (es) Nuevas combinaciones terapeuticas para el tratamiento de la depresion
UY30087A1 (es) Piperazinas y piperidinas como potenciadoras de mglur5
UY30856A1 (es) Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk
ECSP088603A (es) Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4
DOP2006000024A (es) Tiazolidinonas, su preparación y su uso como medicamento
DOP2006000248A (es) Acido 1-(1-(2-etoxietil)-3-etil-7-(4-metilpiridin-2-ilamino)-1h- pirazolo[4,3-d]pirimidin-5-il)piperidina-4-carboxílico y las sales del mismo.